On Friday, Cue Biopharma Inc (NASDAQ: CUE) opened lower -21.58% from the last session, before settling in for the closing price of $0.34. Price fluctuations for CUE have ranged from $0.34 to $1.75 over the past 52 weeks.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 15.39%. Company’s average yearly earnings per share was noted 43.75% at the time writing. With a float of $78.36 million, this company’s outstanding shares have now reached $78.74 million.
Cue Biopharma Inc (CUE) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Cue Biopharma Inc is 0.49%, while institutional ownership is 24.21%.
Cue Biopharma Inc (CUE) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.13 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.14) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 43.75% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.19% during the next five years compared to 15.39% growth over the previous five years of trading.
Cue Biopharma Inc (NASDAQ: CUE) Trading Performance Indicators
Check out the current performance indicators for Cue Biopharma Inc (CUE). In the past quarter, the stock posted a quick ratio of 1.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.46, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.47 in one year’s time.
Technical Analysis of Cue Biopharma Inc (CUE)
Compared to the last year’s volume of 0.29 million, its volume of 1.52 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 5.03%.
During the past 100 days, Cue Biopharma Inc’s (CUE) raw stochastic average was set at 3.58%, which indicates a significant decrease from 6.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0479 in the past 14 days, which was lower than the 0.0572 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6362, while its 200-day Moving Average is $0.7410. Nevertheless, the first resistance level for the watch stands at $0.3026 in the near term. At $0.3369, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.3670. If the price goes on to break the first support level at $0.2382, it is likely to go to the next support level at $0.2081. Should the price break the second support level, the third support level stands at $0.1738.
Cue Biopharma Inc (NASDAQ: CUE) Key Stats
There are currently 78,738K shares outstanding in the company with a market cap of 21.12 million. Presently, the company’s annual sales total 9,290 K according to its annual income of -40,670 K. Last quarter, the company’s sales amounted to 2,150 K and its income totaled -7,450 K.
